Abstract
In cirrhosis, the mechanism(s) for vascular hyporesponsiveness to vasoconstrictors such as, alpha 1-adrenoceptor agonists, vasopressin and angiotensin II, are unclear. Moreover, vascular reactivity to substances such as L-type calcium channel activators is unknown. Thus, pressor dose-response curves to vasoconstrictors [phenylephrine (an alpha 1-agonist, 0.1-500 micrograms/kg) angiotensin II (10-500 ng/kg), vasopressin (0.01-5 IU/kg), and Bay K 8644 (an L-type calcium channel activator, 0.5-50 micrograms/kg)] were obtained in normal rats and in rats with secondary biliary cirrhosis. All experiments were performed in ganglionic-blocked animals to limit the influence of cardiovascular reflexes. Doses of vasoconstrictor necessary to obtain a 40 mmHg increase in arterial pressure (D40) were calculated. Compared to normal animals, rats with cirrhosis had significantly higher D40 values for angiotensin II (171 +/- 57 vs. 344 +/- 41 ng/kg), phenylephrine (2.6 +/- 0.2 vs. 26.4 +/- 10.7 micrograms/kg) and vasopressin (73 +/- 19 vs. 401 +/- 150 mU/kg). Pressor responses to Bay K 8644 did not differ between normal rats and rats with cirrhosis (8.8 +/- 0.9 vs. 10.5 +/- 2.1 micrograms/kg). In conclusion, this study shows that cirrhosis prod...Continue Reading
References
Oct 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F Y LeeR J Groszmann
Mar 30, 1991·Lancet·P Vallance, S Moncada
Feb 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J ClàriaJ Rodés
Mar 1, 1990·Circulation Research·Y T ShenS F Vatner
Apr 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A J MacGilchristJ L Reid
Apr 1, 1990·The Journal of Surgical Research·J V SitzmannG B Bulkley
Sep 1, 1985·Circulation Research·B M Murray, M S Paller
Feb 1, 1988·Journal of Hepatology·Y NavehO S Better
May 1, 1988·Canadian Journal of Physiology and Pharmacology·L M VillamedianaJ M López-Novoa
Jul 1, 1986·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A BomzonL M Blendis
Mar 1, 1987·The Journal of Surgical Research·D GaliA Bomzon
Jan 1, 1982·European Surgical Research. Europäische Chirurgische Forschung. Recherches Chirurgicales Européennes·S KitanoK Inokuchi
Jul 1, 1980·Circulation Research·S WallensteinJ L Fleiss
Sep 1, 1994·Gastroenterology·E AghdassiJ P Allard
Aug 1, 1993·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A CastroJ Rodés
Jan 28, 1993·Nature·M J Berridge
Jan 1, 1993·Journal of Hepatology·A BraillonD Lebrec
Nov 22, 1962·The New England Journal of Medicine·M L MASHFORDT C CHALMERS
Sep 1, 1963·The Journal of Clinical Investigation·C I JOHNSTON, A D JOSE
Nov 10, 2004·Hypertension·Helmy M SiragyRobert M Carey
Jul 1, 1963·The Journal of Clinical Investigation·J H LaraghJ I Meltzer
Citations
Mar 1, 1995·Journal of Hepatology·R Moreau, D Lebrec
Aug 23, 2001·Pharmacology & Therapeutics·P W Hadoke
Jan 1, 1997·Pharmacology & Therapeutics·P W Hadoke, P C Hayes
Feb 1, 1997·Journal of Hepatology·V SafkaD Lebrec
May 5, 1998·Journal of Hepatology·C TrombinoD Lebrec
Oct 18, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Mathieu VinkenVera Rogiers
Sep 1, 1996·Journal of Gastroenterology and Hepatology·R MoreauD Lebrec
Aug 28, 2003·Alimentary Pharmacology & Therapeutics·H Reynaert, A Geerts
Jan 26, 1999·Journal of Gastroenterology and Hepatology·R MoreauD Lebrec
Jun 4, 2004·Journal of Cardiovascular Pharmacology·Saad LahlouGlória Pinto Duarte
Jan 1, 1997·Journal of Hepatology·J Reichen
Apr 9, 2005·World Journal of Gastroenterology : WJG·Han-Chieh LinShou-Dong Lee